Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Pandemic fears: real and imagined

“Pandemic”. Few words in the English language conjure as much fear. The mere utterance evokes images of dying patients, surgical masks, haz-mat suits, a parade of coffins, helpless doctors and nurses, as the contagion spreads, first striking down the el...
Richard (Rick) Mills | February 25, 2020 |

U.S. Treasury Removes China as Currency Manipulator

The U.S. has formally removed China as a currency manipulator, just ahead of the signing of the ‘Phase 1’ deal. Given its past record, will China really change its ways? Kenny Fisher There was another positive develop...
FX Empire | January 14, 2020 |

Overlooked commodity of which China can't get enough

"Virtually every lumber customer we have in the state of Oregon is now cutting for the Chinese market." That quote comes straight from Rick Holley, CEO of Plum Creek Timber ( NYSE: PCL ), the biggest timberland owner in the U.S. The benchmark commodit...
Larsen Kusick | October 28, 2012 |

Critical materials crisis: Diversifying away from China’s monopoly

Author: Jesse Day, Commodity Culture CEO of Leading Edge Materials (TSXV:LEM / OTCQB:LEMIF) Kurt Budge points out China’s dominance in the production and export of critical raw materials such as graphite and rare earths, and why this is a growing...
Research | December 18, 2024 |

Ucore Rare Metals Looks to Shift the Focus From China to the US for REE Supply

Ucore Rare Metals Inc. (TSXV:UCU) is grabbing the mining industry by the horns thanks to its critical minerals separation technology and developing rare earth elements (REE) separation facility in Alaska.
John Ballem | August 25, 2021 |

Changing Europe’s dependency on HREE from China

Leading Edge Materials (TSXV:LEM) provides North American investors a gateway to invest in Europe’s shift to self-sufficiency for critical raw materials. The company’s Norra Kärr project hosts one of the largest HREE deposits in the world...
Research | November 26, 2024 |

Aravive Shares Rise on Positive Patient Data from Phase 1b Ovarian Cancer Study

Shares of Aravive Inc. are trading higher after the firm posted positive data from the initial 12 patients enrolled in the Phase 1b portion of its study of AVB-500 used in the treatment of ovarian cancer. Today, in a late-breaking oral presentation at the European Soc...
Streetwise Reports | September 30, 2019 |

The True Causes Behind the Yield Curve Inversion and Gold

By now, everyone and their brother has heard about the yield curve inversion. How come it has inverted and how much should we read into it? Is it really such a reliable indicator of an upcoming recession? Let’s dig into the true causes behind the inversion and ...
Arkadiusz Sieron | October 7, 2019 |

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

Shares of Iovance Biotherapeutics traded 12% higher today after the firm reported updated clinical data from its phase 2 lifileucel metastatic melanoma trial. Just a few days after reporting third quarter 2019 earnings, late-stage biotechnology company Iovance Biothe...
Streetwise Reports | November 12, 2019 |

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....
Streetwise Reports | April 29, 2020 |
1 2 3 4 5 6 7 8 9 10 ...